Alendronate treatment for osteoporosis: a review of the clinical evidence
- PMID: 9116385
- DOI: 10.1007/BF01629572
Alendronate treatment for osteoporosis: a review of the clinical evidence
Abstract
Bisphosphonates have recently gained an increasing role in the management of osteoporosis. The aminobisphosphonate, alendronate has recently been introduced as a new agent for the treatment of postmenopausal osteoporosis. This paper reviews the clinical evidence for the use of this agent and seeks to assess its place in osteoporosis management.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
